> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Flonase Not Withdrawn Due to Safety/Effectiveness
- URL: https://www.fdaweb.com/flonase-not-withdrawn-due-to-safety-effectiveness/
- Published: 2017-03-06T12:00:00.000Z
- Updated: 2026-09-14T22:09:59.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5138127

*Federal Register* Notice: FDA has determined that GlaxoSmithKline’s allergy drug Flonase (fluticasone propionate) nasal spray, 0.05 mg, was not withdrawn from sale for safety or effectiveness reasons. This determination means the agency will not begin procedures to withdraw ANDA approvals that reference the brand drug product. To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2017-03-06/pdf/2017-04231.pdf?ref=fdaweb.com).